Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > General Catalyst Group Management, Llc > Profile

Instuitional Investor - General Catalyst Group Management, Llc

Fund Profile
Filing Period:
Fund Name: General Catalyst Group Management, Llc
Portfolio Value $188,517,817
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Arrivent Biopharma Inc.
 AVBP 1,494,786 $51,928,866 27.55%
2.
Parabilis Medicines Inc.
 1,600,937 $43,817,646 23.24%
3.
Maplebear Inc.
 CART 710,711 $33,652,166 17.85%
4.
Maze Therapeutics Inc.
 MAZE 1,035,910 $30,911,554 16.4%
5.
Odyssey Therapeutics Inc.
 810,272 $15,160,189 8.04%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.